Pressure BioSciences to Develop Sample Prep for Parabase Genomics' Newborn MDx Service | GenomeWeb

NEW YORK (GenomeWeb) – Pressure BioSciences will develop a sample preparation method for Parabase Genomics' targeted next-generation sequencing-based neonatal molecular diagnostics platform, the companies said today.

Parabase will incorporate Pressure BioSciences' patented Pressure Cycling Technology (PCT) sample prep platform into its LifeTime NewbornDx service, which evaluates 350 genes involved in genetic disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.